Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Current Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Total Current Liabilities for 3 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 38.53% to $22.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.9 million, a 38.53% decrease, with the full-year FY2025 number at $22.9 million, down 38.53% from a year prior.
  • Total Current Liabilities was $22.9 million for Q4 2025 at Metagenomi, down from $29.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $70.7 million in Q1 2024 to a low of $22.9 million in Q4 2025.
  • A 3-year average of $44.6 million and a median of $39.9 million in 2025 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: tumbled 45.82% in 2024, then crashed 35.26% in 2025.
  • Metagenomi's Total Current Liabilities stood at $68.9 million in 2023, then crashed by 45.82% to $37.3 million in 2024, then tumbled by 38.53% to $22.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Total Current Liabilities are $22.9 million (Q4 2025), $29.6 million (Q3 2025), and $33.3 million (Q2 2025).